When you need a trusted partner for your sterile injectable drug products, chose Hikma. We guarantee high-quality, consistency and reliability at every stage. Scale-up processes from R&D level to industrial size. From pilot batches to commercial production with comprehensive fill and finish.
We produce 500 million units a year. And we are expanding our capacity in the EU and US. We offer a wide range of sterile injectable services.
Technology:
IV Bags
Prefilled syringes
Liquid vials
Lyophilised vials
Ampoules
Products:
General formulation liquid solutions
General formulation lyophilisation
Liquid lyophilised biologics
Emulsions
Suspensions
Liquid and lyophilised cytotoxic and high-containment
Cephalosporins
Controlled substances
5 state-of-the-art operational sites:
Bedford, US
Cherry Hill, US
Goslar, Germany
Sintra, Portugal
Pavia, Italy
Full compliance with quality and safety standards.
A strong regulatory track record.
US FDA, EMA, Japan FDA, Jordan FDA, Korea, GCC and ANVISA approved.
Over ten new filings and approvals in EU and US markets every year.
For high-quality, global reach, local capacity and flexible manufacturing, choose Hikma.
High-quality prefilled manufacturing operations in the US